\-\ Texto\\:\\ \ \(0\)\
\-\ mildly\\ decreased\\ sensation\\ to\\ touch\\ in\\ the\\ upper\\ extremities\\ with\\ no\\ motor\\ weakness\\.\\ normal\\ balance\\,\\ and\\ vision\\ with\\ no\\ current\\ visual\\ deficits\\.\ \(0\)\
\-\ the\\ patient\\ is\\ currently\\ on\\ pharmacological\\ therapy\\ for\\ multiple\\ sclerosis\\.\\ she\\ has\\ had\\ a\\ chronic\\,\\ intermittant\\ course\\,\\ so\\ far\\,\\ and\\ seems\\ to\\ be\\ slightly\\ progressing\\ in\\ symptomatology\\.\\ she\\ currently\\ has\\ no\\ symptoms\\ of\\ optic\\ neuritis\\.\ \(0\)\
\-\ axial\\ flair\\ mri\\ sequences\\ demonstrate\\ multiple\\ small\\ foci\\ of\\ increased\\ signal\\ intensity\\ in\\ the\\ periventricular\\ white\\ matter\\ which\\ had\\ increased\\ in\\ number\\ compared\\ to\\ prior\\ mri\\ performed\\ four\\ years\\ prior\\.\\ the\\ left\\ optic\\ nerve\\ was\\ enlarged\\ on\\ the\\ axial\\ t2wi\\ from\\ 2001\\ consistent\\ with\\ the\\ patients\\ symptoms\\ of\\ left\\ optic\\ neuritis\\.\\ the\\ left\\ optic\\ nerve\\ has\\ normalized\\ on\\ the\\ current\\ examination\\ with\\ treatment\\ and\\ the\\ symptoms\\ of\\ optic\\ neuritis\\ have\\ resolved\\.\ \(0\)\
\-\ multiple\\ sclerosis\ \(41\)\
\-\ multiple\\ sclerosis\\,\\ lyme\\ disease\\,\\ migraine\\ headaches\\,\\ vasculitis\\.\ \(0\)\
\-\ 41\\ year\\ old\\ female\\ who\\ originally\\ presented\\ with\\ left\\ optic\\ neuritis\\ in\\ 2001\\,\\ and\\ who\\ was\\ subsequently\\ diagnosed\\ with\\ multiple\\ sclerosis\\ presented\\ to\\ neurology\\ clinic\\ with\\ new\\ bilateral\\ arm\\ numbness\\.\ \(0\)\
\-\ this\\ case\\ deomonstrated\\ an\\ abnormally\\ enlarged\\ left\\ optic\\ nerve\\ in\\ 2001\\,\\ at\\ which\\ time\\ her\\ first\\ mri\\ was\\ performed\\.\\ he\\ optic\\ neuritis\\ has\\ currently\\ resolved\\,\\ but\\ she\\ is\\ presenting\\ with\\ worsening\\ upper\\ extremity\\ numbness\\.\\ her\\ current\\ mri\\ shows\\ progression\\ in\\ the\\ number\\ of\\ abnormal\\ foci\\ in\\ the\\ periventricular\\ white\\ matter\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ optic\\:\\ 0\\.44974856486282305\ \(0\)\
\-\ neuritis\\:\\ 0\\.36349851144326006\ \(0\)\
\-\ sclerosis\\:\\ 0\\.1860717801962286\ \(0\)\
\-\ 2001\\:\\ 0\\.18495177281443023\ \(0\)\
\-\ current\\:\\ 0\\.1715749473295671\ \(0\)\
\-\ multiple\\:\\ 0\\.15971946351337818\ \(0\)\
\-\ currently\\:\\ 0\\.1505052989707852\ \(0\)\
\-\ the\\:\\ 0\\.14334591084375584\ \(0\)\
\-\ nerve\\:\\ 0\\.1397726046108592\ \(0\)\
\-\ periventricular\\:\\ 0\\.1342823470537201\ \(0\)\
\-\ mri\\:\\ 0\\.13409470880276764\ \(0\)\
\-\ in\\:\\ 0\\.12997342385151106\ \(0\)\
\-\ number\\:\\ 0\\.1202436076730354\ \(0\)\
\-\ has\\:\\ 0\\.11932439317224247\ \(0\)\
\-\ resolved\\:\\ 0\\.11733559502776492\ \(0\)\
\-\ she\\:\\ 0\\.11663008889100791\ \(0\)\
\-\ numbness\\:\\ 0\\.11610863404533127\ \(0\)\
\-\ left\\:\\ 0\\.11139106147976846\ \(0\)\
\-\ symptoms\\:\\ 0\\.10719961686800435\ \(0\)\
\-\ foci\\:\\ 0\\.10675810347146553\ \(0\)\
\-\ deomonstrated\\:\\ 0\\.10444278377205969\ \(0\)\
\-\ with\\:\\ 0\\.10230603516845212\ \(0\)\
\-\ matter\\:\\ 0\\.099454186507154\ \(0\)\
\-\ pharmacological\\:\\ 0\\.09186488531992537\ \(0\)\
\-\ intermittant\\:\\ 0\\.09186488531992537\ \(0\)\
\-\ normalized\\:\\ 0\\.09186488531992537\ \(0\)\
\-\ enlarged\\:\\ 0\\.08904358230961992\ \(0\)\
\-\ white\\:\\ 0\\.0861776225560948\ \(0\)\
\-\ her\\:\\ 0\\.08160230656719689\ \(0\)\
\-\ performed\\:\\ 0\\.0772736469057897\ \(0\)\
\-\ presented\\:\\ 0\\.07616863625944373\ \(0\)\
\-\ seems\\:\\ 0\\.07599334457822153\ \(0\)\
\-\ progressing\\:\\ 0\\.07552597778560007\ \(0\)\
\-\ axial\\:\\ 0\\.07544927469749575\ \(0\)\
\-\ symptomatology\\:\\ 0\\.07422848939027774\ \(0\)\
\-\ who\\:\\ 0\\.07388523292482926\ \(0\)\
\-\ migraine\\:\\ 0\\.0738267324996165\ \(0\)\
\-\ prior\\:\\ 0\\.07308063309075827\ \(0\)\
\-\ lyme\\:\\ 0\\.07167374195332579\ \(0\)\
\-\ balance\\:\\ 0\\.07103752847561857\ \(0\)\
\-\ increased\\:\\ 0\\.07063164833856417\ \(0\)\
\-\ t2wi\\:\\ 0\\.0698622516843651\ \(0\)\
\-\ upper\\:\\ 0\\.06979988543602166\ \(0\)\
\-\ neurology\\:\\ 0\\.06905375846203761\ \(0\)\
\-\ was\\:\\ 0\\.0682821560107371\ \(0\)\
\-\ far\\:\\ 0\\.06649901102508567\ \(0\)\
\-\ originally\\:\\ 0\\.06649901102508567\ \(0\)\
\-\ to\\:\\ 0\\.06530815854686536\ \(0\)\
\-\ had\\:\\ 0\\.06507836291615011\ \(0\)\
\-\ abnormally\\:\\ 0\\.06494423322771294\ \(0\)\
\-\ touch\\:\\ 0\\.06406984689365512\ \(0\)\
\-\ of\\:\\ 0\\.06390308989929501\ \(0\)\
\-\ no\\:\\ 0\\.0637129107124328\ \(0\)\
\-\ vasculitis\\:\\ 0\\.06060906445961757\ \(0\)\
\-\ 41\\:\\ 0\\.05988573575019961\ \(0\)\
\-\ progression\\:\\ 0\\.05988573575019961\ \(0\)\
\-\ which\\:\\ 0\\.05939300561665105\ \(0\)\
\-\ on\\:\\ 0\\.05917301956761979\ \(0\)\
\-\ vision\\:\\ 0\\.05656292428164233\ \(0\)\
\-\ deficits\\:\\ 0\\.056134076522803195\ \(0\)\
\-\ sensation\\:\\ 0\\.05596693637833517\ \(0\)\
\-\ visual\\:\\ 0\\.05572071405936951\ \(0\)\
\-\ subsequently\\:\\ 0\\.05572071405936951\ \(0\)\
\-\ flair\\:\\ 0\\.055559459329393726\ \(0\)\
\-\ clinic\\:\\ 0\\.05501230896261381\ \(0\)\
\-\ so\\:\\ 0\\.054936236280341534\ \(0\)\
\-\ and\\:\\ 0\\.05398094973468189\ \(0\)\
\-\ four\\:\\ 0\\.05292492831828335\ \(0\)\
\-\ compared\\:\\ 0\\.05279841988678193\ \(0\)\
\-\ mildly\\:\\ 0\\.05273568605004053\ \(0\)\
\-\ sequences\\:\\ 0\\.05224581896214631\ \(0\)\
\-\ arm\\:\\ 0\\.05212655854459341\ \(0\)\
\-\ motor\\:\\ 0\\.051949965379347686\ \(0\)\
\-\ presenting\\:\\ 0\\.05116007313033956\ \(0\)\
\-\ slightly\\:\\ 0\\.05094404980530108\ \(0\)\
\-\ worsening\\:\\ 0\\.049872324332848036\ \(0\)\
\-\ extremities\\:\\ 0\\.049631286028713834\ \(0\)\
\-\ headaches\\:\\ 0\\.048714885348204284\ \(0\)\
\-\ course\\:\\ 0\\.04824047524772629\ \(0\)\
\-\ weakness\\:\\ 0\\.04766379021340923\ \(0\)\
\-\ diagnosed\\:\\ 0\\.047307837298065286\ \(0\)\
\-\ extremity\\:\\ 0\\.04703843906721859\ \(0\)\
\-\ intensity\\:\\ 0\\.04637347756044633\ \(0\)\
\-\ new\\:\\ 0\\.04518158090650167\ \(0\)\
\-\ first\\:\\ 0\\.044072757266921885\ \(0\)\
\-\ examination\\:\\ 0\\.04179132288272507\ \(0\)\
\-\ decreased\\:\\ 0\\.04045353199749722\ \(0\)\
\-\ years\\:\\ 0\\.04003334184482847\ \(0\)\
\-\ abnormal\\:\\ 0\\.039236575445773136\ \(0\)\
\-\ chronic\\:\\ 0\\.038765360931199914\ \(0\)\
\-\ time\\:\\ 0\\.038710096640983176\ \(0\)\
\-\ he\\:\\ 0\\.0386734014282885\ \(0\)\
\-\ shows\\:\\ 0\\.03833054044868753\ \(0\)\
\-\ therapy\\:\\ 0\\.03752406760799119\ \(0\)\
\-\ signal\\:\\ 0\\.037021629174635126\ \(0\)\
\-\ patients\\:\\ 0\\.03673969955525895\ \(0\)\
\-\ is\\:\\ 0\\.03577044689994734\ \(0\)\
\-\ consistent\\:\\ 0\\.03541186101271225\ \(0\)\
\-\ bilateral\\:\\ 0\\.03509929012039289\ \(0\)\
\-\ demonstrate\\:\\ 0\\.033952168246080223\ \(0\)\
\-\ small\\:\\ 0\\.03368841236740513\ \(0\)\
\-\ case\\:\\ 0\\.03281036648511105\ \(0\)\
\-\ have\\:\\ 0\\.03262526379263268\ \(0\)\
\-\ but\\:\\ 0\\.032295240204758116\ \(0\)\
\-\ female\\:\\ 0\\.03151444632437232\ \(0\)\
\-\ treatment\\:\\ 0\\.031109985715063574\ \(0\)\
\-\ disease\\:\\ 0\\.027414260267137554\ \(0\)\
\-\ normal\\:\\ 0\\.02666509273858657\ \(0\)\
\-\ be\\:\\ 0\\.026493117206211007\ \(0\)\
\-\ from\\:\\ 0\\.025937835595316098\ \(0\)\
\-\ an\\:\\ 0\\.02497381683062981\ \(0\)\
\-\ at\\:\\ 0\\.024667912083515438\ \(0\)\
\-\ this\\:\\ 0\\.02244123570565469\ \(0\)\
\-\ patient\\:\\ 0\\.021241632331356217\ \(0\)\
\-\ year\\:\\ 0\\.020126846797081887\ \(0\)\
\-\ for\\:\\ 0\\.019794557166190118\ \(0\)\
\-\ old\\:\\ 0\\.019328740006116507\ \(0\)\
